Prime Medicine Inc. Launches Groundbreaking AATD Treatment Amid Market Volatility
Prime Medicine Inc. has unveiled a groundbreaking treatment program for Alpha-1 Antitrypsin Deficiency, marking a significant step forward in its mission to revolutionize healthcare through gene editing technology.
3 minutes to read